Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 1989

Study Completion Date

April 30, 2000

Conditions
Burkitt LymphomaLymphoma, Large-Cell, DiffuseLymphoma, Small Noncleaved-Cell
Interventions
DRUG

granulocyte-macrophage colony stimulating factor (GM-CSF)

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH